By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Epigenomics AG 

Kleine Präsidentenstraße 1

Berlin    D-10178  Germany
Phone: 49-30-24-34-5-0 Fax: +49-30-24-34-55-55



Company News
Epigenomics AG Reports Results For The Financial Year Ended December 31, 2014 And Provides Outlook For 2015 3/25/2015 1:50:17 PM
Epigenomics AG Announces Completion Of Enrollment In Epi proColon ADMIT Trial 3/25/2015 10:01:40 AM
First Patients Enrolled In Epigenomics AG’ Epi proColon® ADMIT Study 12/17/2014 1:09:07 PM
Epigenomics AG To Present At Oppenheimer 25th Annual Healthcare Conference 12/10/2014 1:05:55 PM
Epigenomics AG And BioChain Announce Approval Of Epi proColon® In China 12/8/2014 2:09:18 PM
Epigenomics AG Announces 2014 Third Quarter And Nine Month Financial Results And Reports On Operational Highlights 11/11/2014 11:38:02 AM
Epigenomics AG’ Strategic Commercialization Partner Polymedco Reiterates Its Commitment To Support Epi proColon® In The United States 11/3/2014 1:11:36 PM
Results Of Adherence Study Published In BMC Gastroenterology Demonstrate That Epigenomics AG’ Blood-Based Epi Procolon® Improves Compliance To CRC Screening 10/27/2014 9:34:11 AM
Epigenomics AG Raises USD 5.3 Million From Its Strategic Commercialization Partner Biochain Institute, Inc. 10/16/2014 2:00:29 PM
Epigenomics AG Provides Corporate Update 10/1/2014 10:38:04 AM